CD274 and colon adenocarcinoma: In the current study, a low dose of attenuated S. typhimurium (~5x 103 CFUs) was utilized to ameliorate the immunosuppressive tumor microenvironment and, therefore, improve the response rate and therapeutic efficacy of PD-L1 blockade in the murine MC38 colon adenocarcinoma model.